Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Mitsudomi

Showing results (61-70 of 336) with videos related to

Pageof 34
Sort By:
Cancer Science|February 23, 2005
Throwing new light on lung cancer pathogenesis: updates on three recent topicsShuta Tomida, Yasushi Yatabe, Kiyoshi Yanagisawa, et al.
Oncogene|November 26, 2002
Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potentialYasushi Yatabe, Hirotaka Osada, Yoshio Tatematsu, et al.
International Journal of Clinical Oncology|March 24, 2007
Neuroendocrine tumor metastasis to the thyroid glandHiroko Yamada, Yasuhisa Hasegawa, Tetsuya Mitsudomi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinomaTakayuki Kosaka, Yasushi Yatabe, Ryoichi Onozato, et al.
The Journal of Molecular Diagnostics : JMD|April 21, 2004
Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE dataTakaomi Koga, Yoshitsugu Horio, Tetsuya Mitsudomi, et al.
Expert Review of Anticancer Therapy|July 14, 2017
Overcoming resistance to EGFR tyrosine kinase inhibitors in lung cancer, focusing on non-T790M mechanismsKenichi Suda, Christopher J Rivard, Tetsuya Mitsudomi, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2008
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancersTakayuki Fukui, Shoichi Mori, Shunzo Hatooka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patientsHideki Endoh, Yasushi Yatabe, Takayuki Kosaka, et al.
World Journal of Surgery|August 13, 2010
Validation of a nomogram for predicting overall survival after resection of pulmonary metastases from colorectal cancer at a single centerYukihide Kanemitsu, Tomoyuki Kato, Koji Komori, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2013
Personalized therapy on the horizon for squamous cell carcinoma of the lungHan Sang Kim, Tetsuya Mitsudomi, Ross A Soo, et al.
Pageof 34

Showing results (61-70 of 336) with videos related to

Sort By:
Pageof 34
Cancer Science|February 23, 2005
Throwing new light on lung cancer pathogenesis: updates on three recent topicsShuta Tomida, Yasushi Yatabe, Kiyoshi Yanagisawa, et al.
Oncogene|November 26, 2002
Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potentialYasushi Yatabe, Hirotaka Osada, Yoshio Tatematsu, et al.
International Journal of Clinical Oncology|March 24, 2007
Neuroendocrine tumor metastasis to the thyroid glandHiroko Yamada, Yasuhisa Hasegawa, Tetsuya Mitsudomi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinomaTakayuki Kosaka, Yasushi Yatabe, Ryoichi Onozato, et al.
The Journal of Molecular Diagnostics : JMD|April 21, 2004
Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE dataTakaomi Koga, Yoshitsugu Horio, Tetsuya Mitsudomi, et al.
Expert Review of Anticancer Therapy|July 14, 2017
Overcoming resistance to EGFR tyrosine kinase inhibitors in lung cancer, focusing on non-T790M mechanismsKenichi Suda, Christopher J Rivard, Tetsuya Mitsudomi, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2008
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancersTakayuki Fukui, Shoichi Mori, Shunzo Hatooka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patientsHideki Endoh, Yasushi Yatabe, Takayuki Kosaka, et al.
World Journal of Surgery|August 13, 2010
Validation of a nomogram for predicting overall survival after resection of pulmonary metastases from colorectal cancer at a single centerYukihide Kanemitsu, Tomoyuki Kato, Koji Komori, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2013
Personalized therapy on the horizon for squamous cell carcinoma of the lungHan Sang Kim, Tetsuya Mitsudomi, Ross A Soo, et al.
Pageof 34